CCND1 and pancreatic neoplasm: The dysregulation of the miR-15a and miR-16-1 cluster involves multiple oncogenic phenotypes such as cell survival, proliferation, and invasion by directly targeting CCND1 (cyclin D1), WNT3A, and BCL2, evident in prostate and pancreatic cancers.